From the AGM "The collaboration project is at the point where...

From the AGM

"The collaboration project is at the point where Production Equivalent Systems will be supplied to Carl Zeiss in December 2016 for testing and validation over the coming months Subject to testing approvals Optiscan expects to deliver a number of additional systems to Carl Zeiss over the next 12 months • Testing and approvals for CE, FDA and the customised sterile sheath will progress over the next 6-9 months • Launch dates are still subject to the successful and satisfactory testing and timing the of regulatory medical approvals for clinical equipment, systems and accessories in the various jurisdictions"

My understanding from the Perth meeting is that more systems will be delivered in January 2017 for testing, and if all goes to plan more in February 2017 that will go to Doctors for use in the OR. Zeiss want to make sure there are no hitches or glitches in the system. Reputations are at stake here not to mention lives. The systems supplied are paid for by Zeiss.

As far as dumping by "sophs" , that is unlikely. I participated in both the raisings to sophisticated investors and the rights issue as well and have sold none of that stock. I also know there is new blood on the register as a result of these raisings and there are some heavy hitters among them that aren`t interested in taking a small profit from this investment. There has been very little selling pressure over the months which suggests my comments are correct.

Relax everybody and have a great Christmas.